San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...
The U.S. IDE clinical trial will evaluate the safety and effectiveness of the St. Jude Medical™ AMPLATZER™ Duct Occluder II AS (ADO II AS), a first-of-its-kind device specifically designed for closure ...
New Delhi: Doctors at Fortis Escorts Heart Institute, Okhla successfully conducted a rare procedure to save the life of a 1.5-month-old newborn weighing mere 1.8 kgs, who was suffering from patent ...
The pea-sized device is a self-expanding wire mesh that is inserted through an incision in the leg and guided through vessels to the heart, where it is placed to seal the opening. The Food and Drug ...
Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder ...
PDA closure devices are the medical devices to cure congenital heart condition called patent ductus arteriosus (PDA). Patent ductus arteriosus is the opening in between two major blood vessels leading ...
PDA Closure Devices Market research Report is an inestimable supply of insightful data for business strategists. This PDA Closure Devices Market study provides extensive data which enlarge the ...
Patients with patent ductus arteriosus treated with an occlusion device designed for small- to moderate-sized ducts had improved outcomes, according to a study in Catherization and Cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback